Next Generation Sequencing Market
Next Generation Sequencing Market Research Report Information by Technology (Whole Exome Sequencing, Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing], and Whole Genome Sequencing), by Workflow (Pre-sequencing [NGS Library Preparation Kits, NGS Semi-Automated Library Preparation Kits, NGS Automated Library Preparation Kits, and Clonal Amplification], Sequencing, Data Analysis [NGS Primary Data Analysis, NGS Secondary Data Analysis, and NGS Tertiary Data Analysis), by Application (Oncology [Diagnostics and Screening, Companion Diagnostics, and Others], Clinical Investigation [Infectious Diseases, Inherited Diseases, Idiopathic Diseases, Non-Communicable Diseases, and Others], Reproductive Health [Non-invasive Prenatal Testing, Pre-implantation Genetic Testing, Newborn or Genetic Screening, Single Gene Analysis, and Others], Human Leukocyte Antigen Typing or Immune System Monitoring, Metagenomics, Epidemiology and Drug Development, Agrigenomics and Forensics, Consumer Genomics, and Others, by End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Forecast Till 2030.
Global Next Generation Sequencing Market Overview
Next Generation Sequencing Market Size was valued at USD 9.46 billion in 2021 and is projected to grow from USD 11.23 Billion in 2022 to USD 44.24 billion by 2030, exhibiting a compound annual grow..
